← Leaderboards
Philip Kuehl
Lovelace Biomedical Research Institute
$625,408
Attributed
$625,408
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $486.3K · FY2022–25$500K$375K$250K$125K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$625,408 · 1
By mechanism
N01$625,408 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Rising Stars on “Validation”
- Cyrus Wadia · Activate Global, Inc.$24,000,000
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Kevin V Grimes · Stanford University$14,783,804
- Cynthia M Visness · Rho Federal Systems Division, Inc.$14,006,776
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Samuel W Teitelbaum · Arizona State University$13,377,213
Research focus
ValidationAids PreventionAnti-Hiv MicrobicideClinical TrialsDetection MethodHiv InfectionsLevonorgestrelLicensureMicrobicideSexual Hiv TransmissionUnited States National Institutes Of HealthAcquired Immunodeficiency SyndromeNational Institute Of Allergy And Infectious DiseaseNonhuman PrimatePersonsPlasmaPlayPre-ClinicalPre-Exposure ProphylaxisPregnancyPreventPreventionPrevention StrategyPreventive Vaccine
Grant awards (2)
Transfer, Validation and Qualification of Bioanalytical Methods for Detection of Cabotegravir and Levonorgestrel in Rat and Nonhuman Primate Plasma$139,107
N01 · FY2025 · AI · contact PI
Transfer, Validation and Qualification of Bioanalytical Methods for Detection of Cabotegravir and Levonorgestrel in Rat and Nonhuman Primate Plasma$486,301
N01 · FY2022 · AI · contact PI